Healthcare and Pharmaceutical Malaria Vaccines – Paving the Way for a Malaria-fr

Malaria Vaccines Market - Size, Share, Emerging
Trends, Outlook, and Opportunity Analysis, 2016 –
2024
Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine,
Erythrocytic Vaccine, Multi-antigen Vaccine), Agent (Plasmodium Falciparum,
Plasmodium Vivax), Distribution Channel (Hospitals, Clinics, Community
Centers), and Geography - Insights, Opportunity Analysis, and Industry
Forecast till 2024
Nearly half of the global population is at risk of malaria as per stats released by the World Health
Organization (WHO). This in turn has led to increased inclination of various healthcare agencies
towards addressing this major malady. Global non-profit organizations such as the Melinda Gates
Foundation and PATH are working towards developing preventive measures and saving lives of many
in the malaria affected regions. Africa accounts for the largest number of malaria cases and hence, this
region is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline plc.
Mosquirix received EU approval in 2015 and is presently being examined in Africa as a pilot study.
“The Global Malaria Vaccines Market is expected to be valued at US$ 8.5 million in 2016 and is
expected to witness a CAGR of 102.8% during the forecast period (2016 – 2024).”
Download PDF Brochure of Market Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/37
People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention
against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during
2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats,
liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free
treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the
vaccines at a much lower cost forgoing its huge profit margins to support the global malaria
eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria
vaccines market is poised for significant growth in near future.